Win- (3183.T) traded down -1.2 % during a 24 hours period ending at 12:00 PM Central Europe on Tuesday 27th. One Win- stock can currently be bought for about JPY 1,219 on popular exchanges. Current supply of Win- stocks is 27.5 mn. Win- has a current market capitalization of JPY 33.8 bn and approximately JPY 55.1 mn worth of Win- was traded on exchanges in the last 24 hours. Since last month end, Win- has traded -3.61 % down. Simple moving average of last 200 days is at JPY 1,303.29. The highest price of past 52 weeks was recorded at JPY 1,527 on 03/02/2026. 52 weeks low was at JPY 1,175 on 06/03/2026.
Here is how related stocks have performed in the past 24 hours:
Yushiro (5013.T) traded down -2.52 % and now trades at JPY 3,040. Yushiro has a market capitalisation of JPY 39.6 bn. Yushiro has a current price to earnings ratio of 10.04.
Arakawa Chemical Industries (4968.T) traded down -0.65 % and now trades at JPY 2,079. Current market capitalisation for Arakawa Chemical Industries is JPY 40.3 bn. Arakawa Chemical Industries has a current price to earnings ratio of 13.3.
Base (4477.T) traded up 2.06 % and now trades at JPY 338. Current market capitalisation for Base is JPY 39.8 bn. Current price/earnings ratio for Base is 19.82.
Value Hr (6078.T) traded up 0.07 % and now trades at JPY 1,487. Value Hr has a market capitalisation of JPY 39.9 bn. Current price/earnings ratio for Value Hr is 54.78.
Rion (6823.T) traded down -0.46 % and now trades at JPY 3,290. Current market capitalisation for Rion is JPY 40.4 bn. Rion has a current price to earnings ratio of 11.6.
About Win-
WIN-Partners Co., Ltd. is a health care company operating in Japan that specializes in distributing medical devices primarily within that country. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; stent grafts, transcatheter heart valves, and mechanical heart valves. Additionally, they provide peripheral vascular stents, carotid artery stents, and neurovascular occlusion coils; and insulin pumps, X-ray angio systems, and magnetic resonance imaging equipment. This health care provider was founded in 1973 and has its main headquarters in Tokyo, Japan. You can find more information about the company and its offerings on their website at www.win-partners.co.jp , and they are listed on the Tokyo Stock Exchange. Their initial public offering took place on September 10, 2002.